Across TCGA pan-cancer cohorts, CST9LP1 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated CST9LP1 data layer.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CST9LP1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CST9LP1 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.
LUAD, OV, and UCEC are the cancer types where CST9LP1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.